Vimarsana
Biggest News Aggregation in the World

Benjamin Bertrand News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Benjamin Bertrand. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Benjamin Bertrand Today - Breaking & Trending Today

What's the move at EMU? Feb. 6-12 - Vimarsana News

What's the move at EMU? Feb. 6-12

The Eastern Echo, serving the Eastern Michigan University community.

Cardiawave Confirms the Safety of VALVOSOFT its Non-Invasive Ultrasound Treatment for Aortic Stenosis - Vimarsana News

Cardiawave Confirms the Safety of VALVOSOFT its Non-Invasive Ultrasound Treatment for Aortic Stenosis

Successful completion of the FIM II clinical study prior to the pivotal study, that will pave the way for CE marking

Cardiawave SA: Cardiawave Confirms the Safety of VALVOSOFT its Non-Invasive Ultrasound Treatment for Aortic Stenosis - Vimarsana News

Cardiawave SA: Cardiawave Confirms the Safety of VALVOSOFT its Non-Invasive Ultrasound Treatment for Aortic Stenosis

No cerebral vascular anomaly before and after treatment observed - Successful completion of the FIM II clinical study prior to the pivotal study, that will pave the way for CE marking Cardiawave SA

Cardiawave announces French National Agency for the Safety of Medicines and Health Products (ANSM) green light to launch VALVOSOFT Pivotal Study in France - Vimarsana News

Cardiawave announces French National Agency for the Safety of Medicines and Health Products (ANSM) green light to launch VALVOSOFT Pivotal Study in France

Cardiawave SA, a deeptech medical device manufacturer that has developed VALVOSOFT a revolutionary non-invasive medical device to treat aortic stenosis, the most prevalent heart valve disease in adults

Cardiawave SA: Cardiawave Announces the Success of Its Clinical Trial to Treat Aortic Stenosis Using VALVOSOFT, Its Disruptive, Non-Invasive, Ultrasound Treatment - Vimarsana News

Cardiawave SA: Cardiawave Announces the Success of Its Clinical Trial to Treat Aortic Stenosis Using VALVOSOFT, Its Disruptive, Non-Invasive, Ultrasound Treatment

The trial with VALVOSOFT its disruptive, non-invasive, ultrasound treatment was proven to: be safe and feasible provide a sustained repair of the aortic valve improve quality of life